GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sawai Pharmaceutical Co Ltd (TSE:4555) » Definitions » Liabilities-to-Assets

Sawai Pharmaceutical Co (TSE:4555) Liabilities-to-Assets : 0.39 (As of Mar. 2021)


View and export this data going back to 2000. Start your Free Trial

What is Sawai Pharmaceutical Co Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Sawai Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2021 was 円152,591 Mil. Sawai Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2021 was 円393,341 Mil. Therefore, Sawai Pharmaceutical Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2021 was 0.39.


Sawai Pharmaceutical Co Liabilities-to-Assets Historical Data

The historical data trend for Sawai Pharmaceutical Co's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sawai Pharmaceutical Co Liabilities-to-Assets Chart

Sawai Pharmaceutical Co Annual Data
Trend Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.37 0.44 0.40 0.39 0.39

Sawai Pharmaceutical Co Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.39 0.39 0.39 0.39

Competitive Comparison of Sawai Pharmaceutical Co's Liabilities-to-Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Sawai Pharmaceutical Co's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sawai Pharmaceutical Co's Liabilities-to-Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sawai Pharmaceutical Co's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Sawai Pharmaceutical Co's Liabilities-to-Assets falls into.



Sawai Pharmaceutical Co Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Sawai Pharmaceutical Co's Liabilities-to-Assets Ratio for the fiscal year that ended in Mar. 2021 is calculated as:

Liabilities-to-Assets (A: Mar. 2021 )=Total Liabilities/Total Assets
=152591/393341
=0.39

Sawai Pharmaceutical Co's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2021 is calculated as

Liabilities-to-Assets (Q: Mar. 2021 )=Total Liabilities/Total Assets
=152591/393341
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sawai Pharmaceutical Co  (TSE:4555) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Sawai Pharmaceutical Co Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Sawai Pharmaceutical Co's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Sawai Pharmaceutical Co (TSE:4555) Business Description

Traded in Other Exchanges
N/A
Address
5-2-30, Miyahara, Yodogawa-Ku, Osaka, JPN, 532-0003
Sawai Pharmaceutical Co Ltd is a Japan-based pharmaceutical company. It manufactures and sells, imports, and exports pharmaceutical products. The company offers prescription drugs in various formulations, including tablets, oral dispersing tablets, capsules, granules, injections, tapes, syrups and others in the therapeutic areas of cardiovascular, gastro-intestinal, chemotherapeutics, vitamins, anti-cancer and others. The group serves various sectors such as hospitals, general practitioners, and dispensing pharmacies.

Sawai Pharmaceutical Co (TSE:4555) Headlines

No Headlines